Richard Charnin Oct. 7, 2021
Worldwide, more than 50 peer-reviewed studies have shown the effectiveness of ivermectin as a treatment and prophylaxis against COVID-19.A study by the American Journal of Therapeutics that analyzed 18 randomized controlled treatment trials found ivermectin elicited “large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance” in COVID patients.
The study concluded that “the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.
”In February, a peer-reviewed study found that ivermectin reduces coronavirus infections, hospitalizations and deaths by about 75%.Ivermectin, in more than 30 trials around the world, causes “repeated, consistent, large magnitude improvements in clinical outcomes’ at all stages of the disease,” according to the study, which was published in the U.S. journal Frontiers of Pharmacology. https://www.citizensjournal.us/covid-deaths-plunge-after-major-world-city-introduces-ivermectin/
*Note that the total number of deaths associated with the COVID-19 vaccines is greater than the number of deaths associated with all other vaccines combined since the year 1990. Latest VAERS DATA from the CDC of “adverse reactions” to experimental vaccines: http://vaersanalysis.info/2021/10/01/vaers-summary-for-covid-19-vaccines-through-9-24-2021/